MDAshkan

[SVIN @svinsociety]

REGISTRATION NOW OPEN! Join us for the April 22 Virtual Stroke Academy Grand Rounds: Carotid Web with Diogo Haussen, MD!

VSA is a virtual learning environment designed to support education and professional development in vascular neurology. Grand Rounds features expert-led presentations on essential core topics, providing learners with valuable insights from leaders in the field.

Registration found here: https://t.co/GzLkpqezLl

#SVINwebNIR

[MDAshkan @AshkaNeuro]

@Neuralgroover @AANmember The second edition was easily one of the best neurology books I’ve ever read. I’m thrilled that the third edition is on its way! Thank you!

[Staten Island - Lenox Hill Neurology Residency @siuhlhhneuro]

Wishing everyone the best of luck for the match tomorrow!
#Match2025 #MatchDay #neurotwitter @NMatch2025

[AHA Science @AHAScience]

ICYMI – here are all 19 LBS trial results presented at #ISC25.

[Edmonton Stroke Program @EdmontonStroke]

Day 1 #ISC25 International Stroke Conference. It is a very exciting day, and three major MeVo DMVO trial results are presented. At this time, no benefit has been observed with EVT in MeVo or DMVO #Stroke #Neurology #neurotwitter #Stroketwitter @CSC_Stroke

[Dr. Negar Asdaghi @NAsdaghi]

A must read. The growing evidence in support of factor XI inhibitors. Head to head comparison of Abelacimab versus Rivaroxaban in high risk Afib shows better safety profile in favor of Abelacimab. Once a month injection vs daily DOAC ⁦@NEJM⁩ https://t.co/e5XrcmaN7a

[World Stroke Academy @WorldStrokeEd]

#Mondaytip
☝️Stroke recurrence in ICAD isn't just about stenosis severity👉the affected artery matters!

⭕️ICAD trials fail to account for differences in the anatomy of each of the major intracranial vessels

Look at the interesting findings of this review
https://t.co/qEq4BrqmFb

[Stroke AHA/ASA @StrokeAHA_ASA]

2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association https://t.co/XqSW4o02Yo @CBushnellMD @AnjailIbrahim @ChaturvediNeuro @LBGoldsteinMD

[uscneurons @uscneurons]

If you couldn’t attend our first open house, fear not as we’ll be having a second one on 10/16! Come hear about our program + meet our faculty and residents — hope to see you there!

[MDAshkan @AshkaNeuro]

@zach_london @UMICHNeuroRes 👌🏼 so cute 😄

[AHA Science @AHAScience]

Published today in @StrokeAHA_ASA: 2024 AHA/ASA Performance and Quality Measures for Spontaneous Intracerebral Hemorrhage: A Report From the American Heart Association/American Stroke Association

✍🏽 @JoshGoldsteinMD @ClaudeHemphill @CTRMDMS @ErikaTMarulanda

[MDAshkan @AshkaNeuro]

@UrohgtThummar @AANmember @aanam Thank You

[World Stroke Academy @WorldStrokeEd]

#Mondaytip
Pathophysiology of #pregnancy-related #stroke :
🌊Hemodynamic changes
🔗Vascular & connective tissue changes
🩸Changes in coagulation system

From: https://t.co/YiAmewrr6l

[Andreas Charidimou MD, PhD @a_charidimou]

🚨 Management of Cerebral microbleeds ⚫️🧠

📚Everything you need to know in our new review article with @VCI_EricSmith in @StrokeAHA_ASA 👇

#NeuroTwitter #stroke #Neurology #neuropath #stroke #dementia #Alzheimers #biomarker #brain #MedStudentTwitter #AmyloidAngiopathy #CAA #cSVD

https://t.co/11QiJZsZRu

[MDAshkan @AshkaNeuro]

@svinsociety It was amazing Thank You

[Dr. Negar Asdaghi @NAsdaghi]

Apixaban is not superior to ASA in prevention of recurrent stroke in ESUS+ atrial cardiopathy. 4% annual rate of stroke in both arms. No increased sICH with apixaban. What is the future of ESUS therapy? ⁦@hoomankamel⁩ https://t.co/uZE8Gy9CYe

[Staten Island - Lenox Hill Neurology Residency @siuhlhhneuro]

Congratulations to Ashkan pgy4 on getting the AAN 2024 Resident Scholarship! 👏🎉
@AANmember #AAN #neurotwitter #Neurology

[MDAshkan @AshkaNeuro]

@siuhlhhneuro @AANmember Thank You 🙏🏼